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aBstraCt 
Optic nerve sheath meningiomas (ONSM) are rare, slow-growing, benign tumours, which constitute approximately 
2% of all orbital tumours of the anterior visual pathway (or orbital or anterior visual pathway) and 1–2% of all me-
ningiomas. Middle-aged females are primarily affected. Untreated ONSMs usually lead to progressive visual decline, 
colour blindness, and finally complete loss of vision. Surgical excision may result in blindness in the affected eye. 
Stereotactic fractionated radiotherapy has recently shown effectiveness in improving or stabilising remaining visual 
function with minimal procedural morbidity in patients with ONSM. We present a case of a 59-year-old female 
with unilateral optic nerve sheath meningioma treated with stereotactic fractionated radiotherapy. During eight 
months of follow-up we observed persistent oedema of the right optic disc and full visual acuity. Optical coherence 
tomography showed decreased peripapillary nerve fibre layer.
KeY Words: meningioma, optic nerve, optic nerve sheath meningiomas, orbital tumour
Ophthalmol J 2017; Vol. 2, No. 4, 117–123
introduCtion
Tumours of the optic nerve represent approxi-
mately 4% of orbital tumours and can occur at any 
age [1, 2]. Although uncommon tumours such as 
haemangiopericytomas and medulloepitheliomas 
are occasionally reported, the majority are either 
optic nerve gliomas or optic nerve sheath menin-
giomas (ONSMs). While gliomas usually occur in 
children, most ONSMs are slow-growing tumours 
affecting middle-aged persons. Typically, ONSM 
affects middle-aged women with an average age of 
41 years [3]. These lesions can arise primarily from 
the optic nerve sheath or may involve the optic 
nerve secondarily after arising from the cavernous 
sinus, falciform ligament, sphenoid wing, pituitary 
fossa, planum sphenoidale, frontoparietal area, or 
the olfactory groove. Progressive visual loss, optic 
nerve atrophy, and presence of optociliary collateral 
vessels, known as the Hoyt-Spencer triad, are a clas-
sic sign of an ONSM [4]. The most common visual 
field defect is peripheral constriction, although 
other field defects such as blind spot enlargement, 
altitudinal field defects, and central scotomas have 
been described [1, 3, 5]. The diagnosis of ONSM 
is usually made on the basis of clinical and radio-
graphic findings [6]. Meningiomas typically display 
intense homogenous enhancement with gadolin-
ium-enhanced fat-suppression T1-weighted pulse 
sequences in magnetic resonance imaging (MRI) 
[7]. Definitive treatment of ONSMs is challenging, 
however, because of the lesions’ intimate circum-
ferential relationship with the optic nerve and its 
vascular supply. Surgical excision has almost always 
resulted in postoperative blindness in the affected 
eye [1, 8, 9, 10]. Many believe that patients with 
optic nerve sheath meningioma (ONSM) can be 
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observed if there is no evidence of intracranial ex-
tension and if there is mild or no vision loss or, in 
some cases, stable degrees of vision loss [11].
Case report
A 59-year-old female presented to our depart-
ment due to the right-sided optic disc oedema. The 
oedema was detected accidentally during routine 
testing. Before the visit in our clinic the patient 
underwent neurological consultation. Neurologi-
cal examination was unremarkable. The initial CT 
of the brain did not show any abnormalities. On 
examination, visual acuity was 1.0 without cor-
rection in both eyes. The pupils were symmetric, 
properly reactive, absolute afferent papillary defect 
was observed. Anterior segment examination under 
the slit-lamp was within normal limits. The fundus 
examination revealed optic disc oedema in the right 
eye and normal findings in the left eye. Static au-
tomated perimetry (Octopus 900) was performed 
and showed non-specific defects in the visual field 
of the right eye (Fig. 1). Optical coherence tomog-
raphy (OCT) showed decreased peripapillary nerve 
fibre layer (RNFL) in the right eye (Fig. 2), without 
abnormalities in the macular scans (Fig. 3). Labora-
tory tests for Lyme disease and toxoplasmosis were 
negative. The diagnosis of anterior ischaemic optic 
neuropathy (AION) was made. Because after two 
months of observation optic disc oedema was still 
present, MRI of the brain and orbit with contrast 
enhancement was performed. It showed an abnor-
mal area along the entire intra-orbital segment of 
the right optic nerve, about 3 cm long, hyperinten-
sive after intravenous administration of contrast, 
causing compression of the right optic nerve and its 
thinning (Fig. 4). The tumour had no intracranial 
extension along the optic nerve. A diagnosis of optic 
nerve sheath meningioma was made. Additional-
ly, an MRI of the brain showed pathology in the 
left bridge-cerebellum angle, measuring approxi-
mately 7.0 × 4.0 mm, without affecting the brain-
stem. The presence of meningioma was assumed. 
As a treatment, radiotherapy was advised by the 
radiation therapist. The patient underwent radio-
therapy of the right optic nerve sheath meningioma 
with a margin-dose per fraction 1.8 Gy, up to total 
dose of 50.4 Gy with anti-swelling treatment (Dex-
amethasone).
In our eight-month observation the tumour did 
not show progression and the vision remained un-
changed. The optic disc oedema did not resolve, 
but the visual acuity was still full. Optical coher-
ence tomography (OCT) still showed decreased 
peripapillary nerve fibre layer (RNFL) in the right 
eye (Fig. 5).
Figure 1. Static automated perimetry (Octopus 900): non-specific defects in the visual field of the right eye
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Figure 2. Optical coherence tomography (OCT) — decreased peripapillary nerve fibre layer (RNFL) in the right eye
disCussion
ONSMs are rare tumours of the anterior visual 
pathway [1]. Primary ONSMs arise from menin-
go-epithelial cap cells of the arachnoid villi and can 
develop at any location along the entire course of 
the optic nerve sheath [1, 10]. Secondary ONSMs 
may arise from tissues outside the orbit, namely the 
cavernous sinus, falciform ligament, clinoid pro-
cesses, sphenoid wing, pituitary fossa, planum sphe-
noidale, tuberculum sellae, frontotemporal dura, 
and/or olfactory groove, and may secondarily grow 
into the optic nerve sheath. The mean age at pres-
entation of ONSM patients is 40.8 years (42.5 years 
in women and 36.1 years in men; range 3–80 years), 
with 61% of the patient population being females 
[1]. Approximately 4–7% of ONSMs occur in pa-
tients below 20 years of age. Unlike adult ONSM 
patients, there is no gender preference in children 
with ONSMs, and in the paediatric population the 
lesions are often associated with neurofibromatosis 
type 2 [1, 8]. Furthermore, ONSMs in paediatric 
patients are frequently more aggressive, are associ-
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Figure 3. OCT macular scans without abnormalities
Figure 4. MRI of the brain and orbit — optic nerve sheath meningioma of the right eye
ated with higher rates of intracranial extension on 
presentation, have a higher rate of bilateral pres-
entation, and have higher rates of recurrence [1, 8, 
10]. Only 5% of ONSMs present bilaterally, and 
65% of these bilateral lesions are intracanalicular 
[1, 10]. About half of the patients who present with 
bilateral ONSMs also have tumours along the pla-
num sphenoidale in continuity with these lesions, 
a finding that raises questions about the true origin 
of bilateral ONSMs. Bilateral and multifocal pres-
entations of ONSMs are most commonly found in 
patients with neurofibromatosis type 2 [1, 8, 10]. 
The classic triad of optic atrophy, visual loss, and 
the presence of optociliary shunt vessels is pathog-
nomonic for the clinical presentation of ONSMs; 
however, this is present in only a minority of pa-
tients [8, 10, 12, 13]. The most common present-
ing symptom in patients with ONSMs (present in 
approximately 96% of cases) is painless, progressive 
loss of visual acuity or visual field, with progression 
often lasting 1–5 years before presentation [8, 10, 
12, 13]. Commonly reported clinical manifestations 
of ONSM include ipsilateral visual loss, afferent 
pupillary defect, colour vision disturbance, visual 
field defect, proptosis, optic disc oedema, motility 
disturbance, pain, and lower eyelid oedema [14]. 
Patients have symptoms of gradual or rapid visual 
loss, diplopia, or gaze-evoked visual obscurations 
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Figure 5. Optical coherence tomography (OCT) after 8 months of observation — decreased peripapillary nerve fibre layer (RNFL) in the 
right eye
[1, 13, 15]. Ophthalmoscopic examination may re-
veal optic nerve head swelling, contiguous macular 
oedema, nerve pallor, or choroidal folds. Optic disc 
swelling, accompanied by optic nerve pallor, may 
also be observed, as in our case. As visual function 
declines, the optic disc oedema may resolve, leaving 
a pale nerve head. The optic disc may be pale, with 
no prior swelling observed, when the meningioma 
is at the apex or within the optic canal [16]. How-
ever, posterior lesions may also present with optic 
disc swelling [17]. In our case, visual acuity was full 
during the follow-up. Other nonspecific complaints 
may include orbital pain and headaches, which have 
been reported in 2–50% of patients with ONSM 
[8, 10, 12, 13]. The gold standard for visualisation 
of ONSMs is MRI [18,19]. Although CT allows 
visualisation of the tumour, only MR imaging (es-
pecially with post-gadolinium fat-suppression se-
quences) can significantly delineate the optic nerve 
as it courses through the optic canal [18, 19]. Early 
detection of ONSM is essential to initiate early 
intervention and prevent subsequent growth into 
the intracranial cavity. Like intracranial meningi-
omas, ONSMs are contrast-enhancing lesions. The 
classic imaging “tram-tracking” sign can be eas-
ily visualised and consists of the thickened optic 
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nerve sheath containing the lesion surrounding the 
non-enhancing, radiolucent optic nerve [18, 19]. 
This thickened optic nerve can appear as a calcified 
nerve sheath on CT images. On coronal views, 
the tumour demonstrates a doughnut shape, with 
the dense nerve sheath tumour encircling the optic 
nerve. Several imaging patterns of ONSM growth 
have been observed, namely tubular (diffuse, apical 
expansion, anterior expansion), globular, fusiform, 
and focal [10, 18, 19]. Definitive treatment of ON-
SMs is challenging because of the lesion’s intimate 
circumferential relationship with the optic nerve 
and its vascular supply. Surgical excision has almost 
always resulted in postoperative blindness in the 
affected eye [1, 8, 9, 10]. Conservative management 
is indicated if there is no significant progressive 
visual dysfunction or intracranial extension of the 
tumour. Recently, it has been highlighted by Miller 
that surgery to remove an ONSM is rarely, if ever, 
indicated, and radiation is the optimum therapy 
[11]. Radiotherapy, both conventional and stereo-
tactic, has been shown to have good efficacy, with 
local tumour control and stabilisation or improve-
ment in visual function, and has been recommend-
ed as the best option for most cases of progressive or 
advanced disease [1, 8, 10, 12, 20–36]. Despite the 
positive results reported in the literature, concerns 
regarding complications secondary to radiation-in-
duced effects have limited the overall acceptance of 
radiotherapy. 
ConCLusions
In cases of unilateral disc oedema, ONSM 
should be considered as one of the differential di-
agnoses. In cases of optic nerve sheath meningioma 
(ONSM), a team approach involving ophthalmol-
ogists, neurologists, neurosurgeons, radiation thera-
pists, and radiologists is the most beneficial.
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